M, M., MA, S., I, U., E, P., I, H., S, M., . . . A, S. (2022). Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers? Cancers, 14(5), . https://doi.org/10.3390/cancers14051101
Chicago Style (17th ed.) CitationM, Marqués, Sorolla MA, Urdanibia I, Parisi E, Hidalgo I, Morales S, Salud A, and Sorolla A. "Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?" Cancers 14, no. 5 (2022). https://doi.org/10.3390/cancers14051101.
MLA (9th ed.) CitationM, Marqués, et al. "Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?" Cancers, vol. 14, no. 5, 2022, https://doi.org/10.3390/cancers14051101.
Warning: These citations may not always be 100% accurate.